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Background: Early childhood environmental exposures, possibly infections, may be responsible for triggering islet
autoimmunity and progression to type 1 diabetes (T1D). The Environmental Determinants of Diabetes in the Young
(TEDDY) follows children with increased HLA-related genetic risk for future T1D. TEDDY asks parents to prospectively
record the child’s infections using a diary book. The present paper shows how these large amounts of partially
structured data were reduced into quantitative data-sets and further categorized into system-specific infectious
disease episodes. The numbers and frequencies of acute infections and infectious episodes are shown.
Methods: Study subjects (n = 3463) included children who had attended study visits every three months from
age 3 months to 4 years, without missing two or more consecutive visits during the follow-up. Parents recorded
illnesses prospectively in a TEDDY Book at home. The data were entered into the study database during study
visits using ICD-10 codes by a research nurse. TEDDY investigators grouped ICD-10 codes and fever reports into
infectious disease entities and further arranged them into four main categories of infectious episodes: respiratory,
gastrointestinal, other, and unknown febrile episodes. Incidence rate of infections was modeled as function of
gender, HLA-DQ genetic risk group and study center using the Poisson regression.
Results: A total of 113,884 ICD-10 code reports for infectious diseases recorded in the database were reduced to
71,578 infectious episodes, including 74.0% respiratory, 13.1% gastrointestinal, 5.7% other infectious episodes and
7.2% febrile episodes. Respiratory and gastrointestinal infectious episodes were more frequent during winter.
Infectious episode rates peaked at 6 months and began declining after 18 months of age. The overall infectious
episode rate was 5.2 episodes per person-year and varied significantly by country of residence, sex and HLA
genotype.
Conclusions: The data reduction and categorization process developed by TEDDY enables analysis of single
infectious agents as well as larger arrays of infectious agents or clinical disease entities. The preliminary descriptive
analyses of the incidence of infections among TEDDY participants younger than 4 years fits well with general
knowledge of infectious disease epidemiology. This protocol can be used as a template in forthcoming time-dependent
TEDDY analyses and in other epidemiological studies.
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The cause of type 1 diabetes (T1D) is widely considered
to involve the interaction of environmental exposures
with a common genetic predisposition leading to the
autoimmune destruction of the insulin-secreting beta
cells in the pancreas. However, the specific causes and
causal pathways remain largely unknown. Understanding
the role of the environment in the etiology and patho-
genesis of T1D could greatly improve the ability to
prevent the disease. Infections are among the environ-
mental candidates suggested to play a role in T1D.
The Environmental Determinants of Diabetes in the
Young (TEDDY) study evaluates multiple environmental
exposures in a prospective follow-up of children with in-
creased genetic risk for T1D. The specific aim of
TEDDY is to identify and characterize the environmental
factors that may trigger T1D-related autoimmune
process and/or promote progression to clinical T1D [1].
In TEDDY, prospective data on infectious exposures
among study participants are being collected though a
reporting system whereby parents monitor and record
illnesses between clinical visits. In addition, biological
samples such as plasma, stool and nasal swab samples
are being collected at regular intervals. The present
study focuses on the parental reports of acute infec-
tious illnesses.
Infections may either increase or decrease the risk of
T1D, and their mode of action may depend on several
factors, such as 1) the type of infection, e.g. only certain
microbes or only infections in certain anatomical loca-
tion may be related to T1D; 2) the quantity of infections,
e.g. low or high overall rate of infections, 3) timing of
infections, e.g. autoimmunity might be triggered by an
infection only during certain period of age, 4) febrile
host response to infection 5) genetic background of the
infected host and 6) a combination of any of these. Due
to this possible complexity a system enabling a time
dependent analysis of infectious disease data at broad
and specific levels is needed. We therefore sought to
organize the complex data from parental reports so that
single infectious agents as well as broader categories of
infectious agents or clinical disease entities could be
simultaneously analyzed.
Multiple symptoms and signs in various organs and
anatomical sites are often seen during the course of a
single infection [2,3]. This can generate several symptom
reports and /or diagnosis reports during one infection.
These may occur simultaneously on a same day, or se-
quentially with some days in between. If each of these
reports is regarded as a separate infection, the total
number of microbial exposures becomes overestimated.
In order to get closer to the real number of exposures
we designed an infectious episode approach in which in-
fectious disease reports representing presumably thesame infection are merged together into an infectious
episode.
In epidemiological research it is common that associa-
tions observed between reported data and a disease pro-
vide the vital first steps towards generating research
hypothesis. However, when disease incidence is low and
reported environmental exposures are hypothesized to
modulate disease risk, it becomes highly relevant to
understand how reported data is processed. In the
present paper we describe the infectious disease report
processing in great detail to enable validation of results
across studies, which will subsequently generate valid re-
search hypotheses for designing analysis of the costly
biological samples.
The aim of the present paper is 1) to describe how par-
ental reports of children’s infectious diseases were proc-
essed in TEDDY study, 2) to describe the scheme for
creating infectious episodes and 3) to show the numbers
and frequencies of acute infectious diseases and infectious
episodes during first four years of life of TEDDY subjects.Methods
Study subjects
TEDDY is a multicenter prospective follow-up study of
children enrolled in one of six clinical centers in Finland,
Germany, Sweden and the United States (Colorado,
Florida/Georgia and Washington). Newborns invited
into TEDDY study belong to either general population
(GP) or are first-degree relatives (FDR) of a patient with
T1D. The TEDDY cohort was identified and enrolled be-
tween December 2004 and February 2010 through geno-
typing newborns after receiving parents’ informed
consent. Human leukocyte antigen (HLA) class II gene
combinations associated with an increased risk for T1D
were used in genotyping and children with increased
HLA-related risk were invited to participate the follow-
up as previously described [4]. The average absolute risk
for T1D is 4.0% in GP and 13.3% in FDR as compared to
up to 1% absolute risk in background population of
TEDDY countries (T1D incidence is 30-50/100 000 in
Scandinavia, 15-25/100 000 in the US and 5-15/100 000
in Eastern and Central Europe) [4]. As T1D is an end-
point in the TEDDY study, children who develop T1D
are no longer followed in the study. Total number of
subjects in the TEDDY cohort is 8,677. The study proto-
col has been described in detail previously [4] and the
TEDDY Study Group is described in Additional file 1.
Written informed consents were obtained for all study
participants from a parent or primary caretaker, separately,
for genetic screening and participation in prospective
follow-up. The study was approved by local Institutional
Review Boards and is monitored by External Advisory
Board formed by the National Institutes of Health.
Lönnrot et al. BMC Pediatrics  (2015) 15:24 Page 3 of 10Subjects of the present study were identified among
TEDDY cohort at the end of year 2012. We included all
subjects who had attended follow-up visits for four years
since birth, had not progressed to T1D, and had not
missed two or more consecutive study visits. Total num-
ber of subjects in the present study is 3,463 (General
Population n = 3,078, First-degree relatives n = 385), in-
cluding subjects from all study sites: Finland n = 815,
Germany n = 164, Sweden n = 1271, Colorado n = 545,
Florida/Georgia n = 285 and Washington n = 383.
Data collection
Enrollment and completion of the first study clinic visit oc-
curs before the child reaches the age of 4.5 months. After
the enrollment, the subject is expected to attend TEDDY
follow-up visit every 3 month until age 4 years and every
6 months thereafter. Parents are asked to record immedi-
ately child’s environmental exposures (infections, medical
conditions, food intake and life events) in a TEDDY diary
book they keep at home and return to study nurse at eachFigure 1 Flow of infectious disease data recorded with TEDDY book.TEDDY visit. In case of illnesses parents fill in symptoms
and/or diagnoses and the date when the illness first
appeared in the TEDDY diary book. Fever can be reported
as a symptom and/or as a “yes” –answer to a specific ques-
tion asking if the child had fever, defined as temperature
equal to or higher than 38°C or 101°F. This specific ques-
tion was used to classify fever in more detail since systemic
fever may alter the nature of immune response, which
could influence the natural course of the autoimmune
process leading to T1D. Parents return the diary book on
each clinic visit when data is extracted by research nurses
to the TEDDY central database. Clinic visits are scheduled
every three months for the first four years of life and then
biannually until age 15. The TEDDY book pages for illness
reports for 0–2 and 2–5 year old children are shown as
additional files (see Additional files 2 and 3).
Data management
The flow of infectious disease data collection is shown
in Figure 1. At each clinic visit, reported symptoms and
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study nurse according to the current version of World
Health Organization’s International Classification of
Disease (ICD-10) system. ICD-10 codes with either three
or four alphanumerical characters are used. Study doctor
assists with coding on nurse’s request. Symptoms are al-
ways recorded and diagnoses are categorized according
to whether it was set by a health-care professional or
not. “Yes”-answers to the specific fever-question are
extracted as such. The ICD-10 codes and “yes”-fever
reports along with the date of first appearance of the ill-
ness are entered into TEDDY database by study nurse
on each visit. Acute and chronic illnesses are entered
into the database separately. Data extraction form for
acute illnesses is shown as an additional file (see
Additional file 4).
ICD-10 codes for infectious diseases and “yes”-fever
reports were extracted from the database’s section of
acute illnesses and grouped into categories of interest
(see Additional file 5). The extracted ICD-10 codes can
be used for infectious disease analyses as such, if one
wants to evaluate codes for certain microbe/microbes or
codes for certain clinical entity/entities.
An infectious episode approach was designed in order
to reduce the possibility of overestimation of microbial
exposure due to multiple symptom and/or diagnosis
reports during a single microbial infection. For this ap-
proach, the ICD-10 code categories described in
Additional file 5 were arranged into four main categories
representing: respiratory infections, gastrointestinal in-
fections, other infections and unknown febrile infections
(Table 1). Also, time-limits for merging ICD-10 codes
into time-bound infectious episodes are required. Defini-
tions for merging codes are the following:
1) The first infectious episode category is created from
ICD-10 codes regarded as respiratory infections. If
codes belonging to this category were reported
within the same week, i.e. with a maximum of five
days in-between the reports, they were regarded as
one respiratory infectious episode. Gastrointestinal
symptoms are considered to occur frequently in
young children with a respiratory infection and
therefore gastrointestinal symptom codes connected
with respiratory infection codes reported within
same week were considered as part of the respiratory
infectious episode. Any fever reports within same
week with respiratory infection codes were considered
as part of the respiratory infectious episode. Date of
the episode was the date of the first ICD-10 code.
2) The second category of an infectious is created from
ICD-10 codes regarded as gastrointestinal infections.
If codes belonging to this category were reported
within same week they were regarded as onegastrointestinal infectious episode. Any fever reports
within the same week with gastrointestinal infection
codes were considered as part of the gastrointestinal
infectious episode. Date of the episode was the date
of the first ICD-10 code.
3) Third category is reserved for other types of
infections. ICD-10 codes in this category are each
regarded as a separate infectious episode. Any fever
reports within the same week with other infection
codes were considered as part of the other infectious
episode category. Date of the episode was the date of
the ICD-10 code.
4) Fourth category is for unknown febrile infections.
This category includes fever reports which have
been entered into database solely, without any other
ICD-10 code recorded at the same date, nor any
ICD-10 code for infection recorded within a week
before or after the fever report. Date of the episode
was the date of the fever report.
Statistical analyses
Using the date of an infectious episode to determine, the
percent of subjects reporting an infectious episode was
calculated every 3 months over the first 4 years of life.
The rate of infections over the 4 years was modeled as
function of gender, HLA risk group, being GP/FDR and
study center using a multivariate Poisson regression
model. For each categorical variable added into the
model, Wald tests tested for an overall significant differ-
ence across subgroups. Results were presented as rate
ratios (95%CI) or as a percent change in the rate. P-
values less than 0.05 were considered statistically sig-
nificant. Graphs were drawn using graphpad 5.0 and
statistical analysis was performed using SAS 9.3.
Results
Altogether 113,884 ICD-10 code reports for infectious dis-
eases were extracted from the database of acute illnesses
for the 3,463 children followed until 48 months of age. Of
the reported ICD-10 code reports 54,216 were described
with a fever. Additionally 285 fevers were reported with
no ICD-10 code. Numbers of reports in each infectious
disease category are shown in Additional file 5.
The total number of infectious episodes was 71,578 with
an average of 1.6 ICD-10 codes reported per episode. Out
of the total infectious episodes 52,965 (74.0%) were respira-
tory infectious episodes, 9,391 (13.1%) were gastrointestinal
infectious episodes, 4,081 (5.7%) were other infectious epi-
sodes and 5,141 (7.2%) were unknown febrile infections
(Table 1). Seasonal patterns for infectious episode rates
are shown in Figure 2. Respiratory and gastrointestinal in-
fectious episode rates were more frequent during winter-
season, whereas no seasonal trend was observed for other
infectious episodes or unknown febrile infections.
Table 1 Categories of infections arranged into four infectious episode types
Infectious episode type ICD-10 code categories (see Additional file 5) Number of infectious episodes
(% of total 71578)
Percent of febrile
infectious episodes
Respiratory 2.1. Common cold 52965 (74.0) 41.5
2.2. Laryngitis and tracheitis
2.3. Influenza
2.4. Enterovirus
2.15. Respiratory syncytial virus infection
3. TONSILLITIS OR STREPTOCOCCAL PHARYNGITIS
4. SINUSITIS
5. INFECTIONS OF MIDDLE EAR AND MASTOID PROCESS
6. BRONCHITIS AND LOWER RESPIRATORY INFECTIONS
11.1. Conjuctivitis
11.6b. Other bacterial diseases, not elsewhere classified
(respiratory tract)
With any of the above:
1. FEVER
8. GASTROENTERITIS SYMPTOMS
Gastrointestinal 7. INFECTIVE GASTROENTERIS 9391 (13.1) 36.6
8. GASTROENTERITIS SYMPTOMSa
With any of the above
1. FEVER
Other 2.5. Chicken pox/Varicella 4081 (5.7) 54.0
2.6. Zoster
2.7. Erythema infectiosum [fifth disease, parvovirus]
2.8. Exanthema subitum
2.9. Measles
2.10. Mumps
2.11. Rubella
2.12. Herpes simplex virus infection
2.13. Other viral rash
2.14. Infectious mononucleosis
2.16. Viral infections of the central nervous system,
not elsewhere classified
2.17. Other virus infections, not elsewhere classified
2.18. Viral warts and molluscum
9. PARASITES
10. MYCOSE
11.2 Infections of external ear
11.3. Urinary tract infections
11.4. Other genitourinary infections
11.5. Bacterial skin diseases
11.6a. Other bacterial diseases, not elsewhere classified
(non-respiratory tract)
11.7. Diseases of oral cavity
11.8. Lymphadenitis
11.9. Infections related to pregnancy, childbirth and puerperium
11.10. Perinatal/neonatal infections
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Table 1 Categories of infections arranged into four infectious episode types (Continued)
11.11. Other and unspecified infections
With any of the above
1. FEVER
Unknown febrile 1. FEVER without any ICD-10 code reported within a week prior
or after.
5141 (7.2) 100
agastroenteritis symptom associated with respiratory illness was not considered gastrointestinal.
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Figure 3. The infectious episode rates peaked steeply at
6 months and started to decline after 18 months. The
overall infectious episodes rates were 5.2 episodes per
person year, including: respiratory infections 3.8 per per-
son year, gastrointestinal infections 0.7 per person year,
other known infection 0.3 per person year and unknown
febrile infections 0.4 per person year. Peak rates for
these infectious episodes were 4.7 for respiratory tract
infections at 9 months, 1.0 for gastrointestinal infections
at 18 months, 0.4 for other known infections at
12 months and 0.6 for unknown febrile infections at
18 months.A
C
Figure 2 Infectious episode rates by season. Respiratory (A, n = 52 965
febrile (D, n = 5141) infectious episode rates by season, divided into febrileIncidence rate of infectious episodes was almost 50%
higher in the European study sites as compared with US
study sites (p < 0.001, Table 2). There was a slight excess
of infectious episodes among males (rate ratio = 1.04,
95%CI = 1.02 – 1.05, p < 0.001). While the rate of infec-
tions differed significantly by the HLA-DR-DQ genotype
(p < 0.001), the differences were small (Table 2). The
FDR status was associated only with non-febrile infec-
tious episodes (Table 2). When respiratory and gastro-
intestinal infectious episodes were evaluated separately,
the associations with gender, FDR status and HLA-DR-
DQ genotype were similar to that seen for all infectious
episodes: However, within the US sites reporting ofB
D
), Gastrointestinal (B, n = 9391), other (C, n = 4081) and unknown
(red line) and non-febrile (blue line).
A B
Figure 3 Infectious episode rates by age. Infectious episode rates by age is shown for febrile (red line) and non-febrile (blue line) in A, and for
respiratory (blue line), gastrointestinal (red line), other (green line) and unknown febrile (brown line) in B.
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tory infections less frequent in Colorado compared to
Georgia/Florida and Washington State (data not shown).
Discussion
TEDDY study seeks to evaluate multiple environmental
factors to identify those associated with the autoimmune
process leading to T1D. Some environmental exposuresTable 2 Infectious episode rates by subject attributes
Factor A. Any infectious episode rate
ratios (RR)
B. Fe
ratio
RR 95%CI p-value RR
Site
US-Colorado 1.00 ref 1.00
US-Georgia 1.18 1.14 – 1.22 1.30
US-Washington 1.05 1.02 – 1.09 1.03
Europe – Finland 1.50 1.46 – 1.54 1.95
Europe – Germany 1.40 1.34 – 1.45 1.80
Europe - Sweden 1.42 1.39 – 1.46 <0.001 2.39
Gender of child
Female 1.00 ref 1.00
Male 1.04 1.02 – 1.05 <0.001 1.03
First degree relative with T1D
No 1.00 ref 1.00
Yes 1.01 0.98 – 1.04 0.40 0.97
HLA-DR-DQ genotype
DR4-DQ8/DR4-DQ8 1.00 ref 1.00
DR3-DQ2/DR4-DQ8 1.02 1.00 – 1.04 0.99
DR4-DQ8/DR8-DQ4 0.97 0.94 – 0.99 0.97
DR3-DQ2/DR3-DQ2 0.99 0.97 – 1.01 0.92
HLA-FDR specifica 0.98 0.93 – 1.03 <0.001 1.01
aFDR HLA-DR-DQ genotypes are DR4-DQ8 with either DR4-DQ4.2, DR13-DQ6.4, DR
Multiple Poisson regression models examining the infectious episode rates by site,
T1D. Rate ratios show risk of A) any type of infectious episode, B) febrile and C) noncan be assessed by analyzing the biological samples
taken from the study subjects, but TEDDY book paren-
tal reporting system is equally important, as it gives day-
to-day information on a large variety of exposures:
symptomatic infections, other medical conditions, medi-
cations, dietary factors and psychosocial factors. Record-
ing of multiple environmental exposures enables not
only analysis of multiple types of exposures separately,brile infectious episode rate
s (RR)
C. Non-febrile infectious episode
rate ratios (RR)
95%CI p-value RR 95%CI p-value
ref 1.00 ref
1.23 – 1.37 1.12 1.07 – 1.16
0.97 – 1.09 1.06 1.02 – 1.10
1.87 – 2.04 1.28 1.24 – 1.32
1.69 – 1.92 1.19 1.13 – 1.25
2.30 – 2.49 <0.001 0.94 0.91 – 0.97 <0.001
ref 1.00 ref
1.00 – 1.05 0.02 1.05 1.03 – 1.07 <0.001
ref 1.00 ref
0.93 – 1.01 0.19 1.05 1.01 – 1.09 0.02
ref 1.00 ref
0.96 – 1.02 1.05 1.02 – 1.08
0.93 – 1.01 0.96 0.93 – 1.00
0.89 – 0.95 1.05 1.02 – 1.09
0.94 – 1.09 <0.001 0.95 0.89 – 1.02 <0.001
12-DQ5.1, DR4-DQ7, DR4-DQ2, DR9-DQ9 or genotype DR3-DQ2/DR9-DQ9.
gender, HLA-DR-DQ genotype and family history of a first degree relative with
-febrile infectious episode rates relative to reference group.
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exposures on the risk of T1D. Infectious disease data
will be included into multiple analyses within TEDDY
aiming at elucidating the environmental risk factors, or
protective factors, and their possible interactions in T1D
pathogenesis.
Data processing is of crucial importance, as it strongly
influences the data analyses and results that follow. Pro-
cessing of infectious disease reports is not straightfor-
ward, as the processed data should allow analysis of
single infectious agents as well as broader categories of
infections. Infectious disease data processing should also
take into account the possibility of multiple reports dur-
ing the course of a single infection. Therefore, there is a
clear need for standardization of the procedures used to
process the data regarding infectious diseases prior to its
use in different kind of studies. Here we describe such
procedures which have been developed in the TEDDY
study and which are applicable also to other large scale
clinical studies. We are not aware of equally detailed de-
scription of infectious disease report processing in previ-
ous literature.
Symptoms of the common childhood infections, i.e.
respiratory and gastrointestinal infections, are often
non-specific and the causative microbe can usually not
be concluded based on clinical picture. Furthermore, the
course of the common infections is often mild and self-
limited, which is why identification of the causative mi-
crobe by laboratory analyses is not necessary in normal
clinical practice. For these reasons, a majority of child-
hood infections do not receive a microbe-specific diag-
nosis, but a diagnosis based on anatomical site of
infection and its symptoms. Also, in the present study,
the majority of the infectious disease reports were not
microbe-specific but based on the site of the infection
and symptoms it caused (Additional file 5). These data
are therefore not optimal for the identification of spe-
cific microbes causing these infections, unless the mi-
crobe of interest happens to have a distinct clinical
presentation, which usually leads to correct microbe
specific diagnosis, e.g., in varicella. In addition, causa-
tive microbes may become identified if they cause
severe infections, which require efficient treatment and
rigorous laboratory analyses, e.g., in meningitis or
streptococcal infection.
One might criticize inclusion of gastrointestinal symp-
toms in the “Respiratory infectious episodes”. This deci-
sion was justified by the fact that nausea and vomiting
in young children are not straightforwardly indicative of
a gastrointestinal infection, as these symptoms can also
be induced by many respiratory infections [5,6]. We
therefore decided to interpret nausea and vomiting as
symptoms of respiratory tract infection, if these symptoms
occurred together with respiratory tract symptoms/diagnoses. This may possibly lead to underestimation of
the number of gastrointestinal infections. Still, we feel that
our interpretation is justified in the present study evaluat-
ing infections in these young 0–4 year old children. One
might also ask why conjunctivitis is included into
“Respiratory infectious episodes”. This inclusion was made
as conjunctivitis in children is often caused by same vi-
ruses and bacteria causing upper respiratory infections,
and in these cases both conjunctival and respiratory symp-
toms present usually simultaneously [6,7]. Enterovirus in-
fections were also included into “Respiratory infectious
episodes”, since symptoms of non-polio enteroviruses
manifest most often in respiratory tract as e.g. herpangina,
hand, foot and mouth syndrome, pharyngitis and croup
[8]. Mild febrile illness with or without rash is also com-
mon, as well as conjunctivitis, whereas the more severe
and less common manifestations include meningitis, en-
cephalitis, myocarditis and sepsis [8]. Gastroenteral symp-
toms are rare, although enteroviruses replicate also in the
intestinal lymphoid tissue and are often detectable in stool
during infection.
The total number of ICD-10 code reports extracted
from database was 113,884. If we had taken each of
these as an indication of an infection, we would have
had a mean of 8.2 annual infections per child. This
would probably have been an overestimation of the
number of symptomatic infections, as a single microbe
often generates multiple symptoms and diagnoses as the
infection spreads to different anatomical sites. Many of
the extracted ICD-10 codes were reported within a
week, many even on same day, and if these codes
belonged to the same main group of codes (Table 1) they
were merged into a single infectious episode. Each epi-
sode may thus include several diagnoses and/or symp-
toms, e.g. common cold together with middle ear
infection and fever, but we assume that there is only one
microbe causing these. By this ICD-10 code merging
procedure we ended up with 71,578 infectious episodes,
translating to a mean of 5.2 annual infectious episodes
per child. This rate is comparable to the extrapolated
yearly rate of infectious events in the BABYDIET study
cohort during first three years of life [9]. Most of the in-
fectious episodes were respiratory tract infections, as ex-
pected. The incidence of respiratory infectious episodes,
the shape of the slope in the incidence according to age,
as well as the higher incidence in winter period are all in
line with previous reports on occurrence of respiratory
infections in young children [10,11]. Also in gastrointes-
tinal disease outbreaks a clear seasonal distribution has
been observed with more cases during winter months
[12], and the same observation was made in the present
study. These findings suggest reasonable soundness and
validity for the used data collection, processing and in-
fectious episode approach.
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as compared with females. Several studies have reported
gender differences in the incidence and severity of infec-
tious diseases. Higher incidence of most respiratory tract
infections has been reported in males [13,14], which
may account for the male preponderance in the present
study, as most of the infectious episodes in this study
were of respiratory type.
HLA has been shown to influence the severity and
outcome of many viral and bacterial infections [15-18].
Slight differences between HLA groups were observed
also in the present study. Having HLA-DR4-DQ8
seemed to increase the risk of febrile infections, whereas
non-febrile infections were more common in the HLA-
DR3-DQ2 group. When looking at febrile and non-
febrile infections together, highest rate was seen in the
HLA-DR-DQ 3-2/4-8 group. These differences between
the HLA groups may be due to different infectious
disease susceptibility due to differences in antigen
presentation.
While reporting of infectious episodes was notably
more frequent in European sites as compared with US
sites, the rates were relatively similar within sites from
each continent. There was a minor cross-continental dif-
ference in recording fever, as in Europe the threshold for
fever was slightly lower (38°) than in the US (101°F
equals to 38,33°C). Differences in access to child-care,
exposure risk to infections, hyper vigilance among some
families from countries with high incidence for T1D,
and reporting bias of infections are some explanations
for the differences in rates between sites. However, these
explanations are unlikely to explain the statistically sig-
nificant differences in infectious episode rates between
HLA-DR-DQ groups as parents were not told of their
child’s specific HLA risk group. Therefore the risk of
exposure and reporting bias are likely to be non-
differential between groups. Future work will examine
demographic and psychosocial factors in relation to the
reported infectious episode rates, and compare the re-
ported infection rates with biomarkers determined from
biological samples.
This study has its limitations. Parental reporting of
infectious diseases captures only symptomatic infections,
which is generally considered to represent only a frac-
tion of all microbial exposures. Reporting of infections
can also be prone to variation between families due to
varying level of study compliance and vigilance in no-
ticing symptoms. Another possible limitation is the ped-
antry of ICD-10 coding system, which can lead to
variation in translation of parental reports into ICD-10
codes, especially if countries have different national
guidelines and conventions in using ICD-10 codes.
Possible variations in the use of ICD-10 codes can be
overcome by using the infectious episode approachdeveloped in this study, as in this mode of analysis same
sort of infections fall under same category even if the
infections would have been recorded using slightly dif-
ferent ICD-10 codes. We also noticed, that it was some-
times difficult for the research nurses to differentiate
between ICD-10 codes for acute and chronic infections,
since some ICD-10 codes for chronic infections had
been entered into the database as acute illnesses. The
total number of chronic infections misclassified as acute
infections in the database was low (n = 116) by chronic
middle ear infections accounting for most (n = 97, de-
tailed data not shown).
Conclusions
Several processing steps are required before parental re-
ports of children's symptoms and illnesses are ready for
analysis. In this paper we have described how parental
data is processed into individual ICD-10 codes, infec-
tious disease categories and infectious episodes in
TEDDY study. These data levels enable time dependent
analysis of single infectious agents as well as larger
arrays of infectious agents or clinical disease entities,
and they are suitable also for analyses of interactions be-
tween infections and other environmental exposures in
T1D pathogenesis. The primary descriptive data of infec-
tions during TEDDY follow-up fits well with general
knowledge of infectious disease epidemiology. This study
protocol for infectious disease data processing can be
used as a standard in the forthcoming analyses within
TEDDY and also as a model to document infectious ex-
posures in other epidemiological studies.
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